Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
NovoCure revenue increased from $351.3 million in 2019 to $494.4 million in 2020, a (40.7%) increase.

Annual Revenue ($)

NovoCure revenue was $494.37 m in FY, 2020 which is a (40.7%) year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2018FY, 2019FY, 2020
Revenue$248.07 m$351.32 m$494.37 m
Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021
Revenue$52.13 m$61.51 m$64.76 m$73.31 m$86.71 m$92.06 m$101.83 m$115.93 m$132.66 m$134.7 m

Annual Growth Rate (%)

Revenue Breakdown

Geographic Segment

NovoCure revenue breakdown by geographic segment: 68.9% from United States, 18.9% from Germany, 5.9% from Japan and 6.3% from Other

FY, 2020FY, 2019FY, 2018
United States$340.78 m$232.81 m$168.41 m
Germany$93.26 m$86.56 m$67.85 m
Other EMEA$18.65 m$8.78 m$4.65 m
Japan$29.08 m$17.91 m$6.35 m
Greater China$12.59 m$5.26 m$802 k

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu